Bottom line
Is RYLVX a good fund? The bottom line
RYLVX is the Class A share class of S&P 500 Pure Value Fund, an actively managed large value mutual fund from Guggenheim.
Its expense ratio is 1.54% — about $154 a year on every $10,000 invested, more expensive than 89% of large value funds we track.
It returned +11.0% over one year, +11.0% a year over five years, +8.2% a year over ten (as of Dec 31, 2025, per its prospectus).
With $63.2 million in net assets and 122 holdings, its largest position is Centene Corp (2.7%) and the top 10 make up 20.6% of the portfolio.
This share class carries a front-end sales charge of up to 4.75%; a no-load class or ETF alternative can avoid it.
The closest lower-cost alternative we found is RPV (0.35%, 78% top-holdings overlap).
What to watch
- Expensive for its category (1.54%)
- Front-end sales load up to 4.75%
- 12b-1 marketing fee of 0.25% a year
- High turnover (2,128% a year) can mean more taxable distributions
Updated Nov 19, 2026
What RYLVX invests in
The S&P 500 Pure Value Fund (the Fund) seeks to provide investment results that match, before fees and expenses, the performance of a benchmark for large-cap value securities on a daily basis. The Funds current benchmark is the S&P 500 Pure Value Index (the underlying index).
The Fund employs as its investment strategy a program of investing in the common stock of companies that are generally within the capitalization range of the underlying index and derivative instruments, which primarily consist of equity index swaps, futures contracts, and options on securities, futures contracts, and stock indices. While the Fund may write (sell) and purchase swaps, it expects primarily to purchase swaps. Equity index swaps and futures and options contracts enable the Fund to pursue its investment objective without investing directly in the securities included in the underlying index or in the same proportion that those securities are represented in the underlying index. Certain of the Funds derivatives investments may be traded in the over-the-counter (OTC) market. Under normal circumstances, the Fund will invest at least 80% of its net assets, plus any borrowings for…
From the fund's prospectus (filed Jul 29, 2026).
RYLVX performance
| 1 yr | 5 yr | 10 yr | |
|---|---|---|---|
| RYLVX | +11.0% | +11.0% | +8.2% |
| Large Value median | +13.6% | +11.3% | +10.2% |
Source: Fund prospectus, as of Dec 31, 2025
What RYLVX costs
On a $10,000 investment, RYLVX's 1.54% expense ratio costs about $154 a year. The prospectus estimates $2,270 in total costs over 10 years (assuming 5% annual returns). The median large value fund charges 0.81%.
RYLVX top 10 holdings
| # | Holding | % of fund |
|---|---|---|
| 1 | Centene Corp CNC | 2.73% |
| 2 | Humana Inc HUM | 2.47% |
| 3 | Archer Daniels Midland Company ADM | 2.21% |
| 4 | Bunge Global Sa BG | 2.20% |
| 5 | Cvs Health Corp CVS | 2.14% |
| 6 | Ford Motor Co F | 2.00% |
| 7 | Dow Inc DOW | 1.78% |
| 8 | General Motors Company GM | 1.71% |
| 9 | Target Corp TGT | 1.66% |
| 10 | Cigna Group (the) CI | 1.66% |
Source: SEC Form N-PORT, period ended Jun 30, 2026
The top 10 make up 20.6% of the fund. See all top 25 holdings and asset mix →